Bellevue Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $549K | Sell |
|
|||||
|
2024
Q2 | $17M | Sell |
|
|||||
|
2024
Q1 | $27.9M | Sell |
|
|||||
|
2023
Q4 | $49.2M | Buy |
|
|||||
|
2023
Q3 | $30.2M | Buy |
|
|||||
|
2023
Q2 | $47.2M | Sell |
|
|||||
|
2023
Q1 | $73.2M | Buy |
|
|||||
|
2022
Q4 | $57.1M | Buy |
|
|||||
|
2022
Q3 | $68.8M | Sell |
|
|||||
|
2022
Q2 | $54.6M | Buy |
|
|||||
|
2022
Q1 | $55.8M | Buy |
|
|||||
|
2021
Q4 | $30.8M | Buy |
|
|||||
|
2021
Q3 | $1.58M | Hold |
|
|||||
|
2021
Q2 | $3.03M | Hold |
|
|||||
|
2021
Q1 | $2.06M | Hold |
|
|||||
|
2020
Q4 | $2.75M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $801K | Buy |
|